ConductScience.org, home

Paper33560416

Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).

Barajas RF and 20 others. Neuro Oncol, 2021. Cited by 147 papers, by iCite.

Cite this record

ConductScience Library. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). Papers, record 33560416. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33560416

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG).
PubMed
Journal
Neuro Oncol
PubMed
Year
2021
PubMed
Publication types
Consensus Statement, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
147
iCite
Relative citation ratio, by iCite
10.5
iCite
Revised in PubMed
2026-03-04
PubMed

Authors21

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barajas RFRamon Fhttps://orcid.org/0000-0001-5093-4168
2Politi LSLetterio Shttps://orcid.org/0000-0002-6190-6688
3Anzalone NNicolettahttps://orcid.org/0000-0002-4249-2723
4Schöder HHeikohttps://orcid.org/0000-0002-5170-4185
5Fox CPChristopher P
6Boxerman JLJerrold L
7Kaufmann TJTimothy J
8Quarles CCC Chad
9Ellingson BMBenjamin Mhttps://orcid.org/0000-0002-2764-6640
10Auer DDorothee
11Andronesi OCOvidiu C
12Ferreri AJMAndres J M
13Mrugala MMMaciej M
14Grommes CChristian
15Neuwelt EAEdward A
16Ambady PPrakash
17Rubenstein JLJames L
18Illerhaus GGerald
19Nagane MMotoohttps://orcid.org/0000-0002-0018-1652
20Batchelor TTTracy T

Source PubMed

See all 21 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Central Nervous System NeoplasmsMajor topic
LymphomaMajor topic
Humans
Central Nervous System
Magnetic Resonance Imaging
Positron-Emission Tomography
Reproducibility of Results

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 CA220378NCI NIH HHSUnited StatesU01CA220378PubMed and NIHNIH RePORTER
R21 NS082609NINDS NIH HHSUnited StatesR21NS082609PubMed and NIHNIH RePORTER
L30 CA220897NCI NIH HHSUnited StatesL30CA220897PubMedNIH RePORTER
R01 CA239462NCI NIH HHSUnited StatesR01CA239462PubMedNIH RePORTER
P50 CA211015NCI NIH HHSUnited StatesP50CA211015PubMed and NIHNIH RePORTER
R01 CA139083NCI NIH HHSUnited StatesR01CA139083PubMed and NIHNIH RePORTER
R01 CA221938NCI NIH HHSUnited StatesR01CA221938PubMed and NIHNIH RePORTER
EP-C-15-003EPAUnited StatesPubMedPubMed
K08 CA237809NCI NIH HHSUnited StatesK08CA237809PubMed and NIHNIH RePORTER
R01 CA158079NCI NIH HHSUnited StatesR01CA158079PubMedNIH RePORTER
R21 CA223757NCI NIH HHSUnited StatesR21CA223757PubMed and NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT06263361Improving Safety and Accuracy of Stereotactic Brain Biopsies in Primary Central Nervous System Lymphoma.Background

Source ClinicalTrials.gov

Download CSV of trials

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18896625Rapidly progressive dementia caused by nonenhancing primary lymphoma of the central nervous system.AJNR Am J Neuroradiol1996https://conductscience.org/library/papers/8896625PubMed
219186405Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.Neoplasia2009https://conductscience.org/library/papers/19186405PubMed
322228634Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.Clin Cancer Res2012https://conductscience.org/library/papers/22228634PubMed
427502247MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis.Neuro Oncol2017https://conductscience.org/library/papers/27502247PubMed
522711606Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.Neuro Oncol2012https://conductscience.org/library/papers/22711606PubMed
618287338The utility of body FDG PET in staging primary central nervous system lymphoma.Neuro Oncol2008https://conductscience.org/library/papers/18287338PubMed
729848919Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.Magn Reson Med Sci2019https://conductscience.org/library/papers/29848919PubMed
828379322International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).Ann Oncol2017https://conductscience.org/library/papers/28379322PubMed
928640701Primary CNS Lymphoma.J Clin Oncol2017https://conductscience.org/library/papers/28640701PubMed
1030033836Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma.Leuk Lymphoma2019https://conductscience.org/library/papers/30033836PubMed
1122322605The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard.AJNR Am J Neuroradiol2012https://conductscience.org/library/papers/22322605PubMed
1226250565Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.Neuro Oncol2015https://conductscience.org/library/papers/26250565PubMed
131552337Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.J Nucl Med1992https://conductscience.org/library/papers/1552337PubMed
1420602148Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions.J Neurooncol2011https://conductscience.org/library/papers/20602148PubMed
1532048719Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.Neuro Oncol2020https://conductscience.org/library/papers/32048719PubMed
1615955902Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.J Clin Oncol2005https://conductscience.org/library/papers/15955902PubMed
1727666608Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.Eur J Radiol2016https://conductscience.org/library/papers/27666608PubMed
188524024MR contrast due to intravascular magnetic susceptibility perturbations.Magn Reson Med1995https://conductscience.org/library/papers/8524024PubMed
1917406788Angiogenesis in primary central nervous system lymphoma (PCNSL).J Neurooncol2007https://conductscience.org/library/papers/17406788PubMed
2022936096Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma.AJNR Am J Neuroradiol2013https://conductscience.org/library/papers/22936096PubMed

See all 49 referencesDownload CSV of references

Cited by105

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 147 citations.

PMIDTitleJournalYearIn PapersSource
42823715Advances in molecular pathobiology of PCNSL - towards clinical implementation of novel diagnostics and therapeutics.Biomark Res2026https://conductscience.org/library/papers/42823715PubMed
42814177Primary central nervous system lymphoma in the molecular era: genomic drivers, liquid biopsy, and targeted therapeutic strategies.Ann Hematol2026https://conductscience.org/library/papers/42814177PubMed
42756914Clinical trial design for primary brain tumors: a problem-based framework for neuro-oncology practice.Front Oncol2026https://conductscience.org/library/papers/42756914PubMed
42741313Efficacy and safety of rituximab in the treatment of primary central nervous system lymphoma: A meta-analysis and systematic review of 1,388 patients.Oncol Lett2026https://conductscience.org/library/papers/42741313PubMed
42490843Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System and Systemic Classic Hodgkin Lymphoma in the Same Patient.J Hematol2026https://conductscience.org/library/papers/42490843PubMed
42453186Primary central nervous system lymphoma-current standards and recent developments.Neurooncol Pract2026https://conductscience.org/library/papers/42453186PubMed
42444831Preoperative phenotypic stratification of primary central nervous system lymphoma using multiparametric MRI-based radiomics: prediction of germinal center B-cell-like and double-expression status.Front Oncol2026https://conductscience.org/library/papers/42444831PubMed
42410107Radiological and FDG-PET imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas.J Neurol2026https://conductscience.org/library/papers/42410107PubMed
42359975Modern Cyanine Dye-Based Photosensitizers for Medical Applications.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42359975PubMed
42339340Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.Hemasphere2026https://conductscience.org/library/papers/42339340PubMed
42265756CSF ctDNA Molecular Clearance as a Prognostic Biomarker for Orelabrutinib-Treated Primary Central Nervous System Lymphoma: Insights From Comparison With PET-CT.Am J Hematol2026https://conductscience.org/library/papers/42265756PubMed
42213292Candidate MRI biomarkers for CD79B status in primary CNS lymphoma: an exploratory radiogenomic analysis of the UCSF-PCNSL cohort.J Neurooncol2026https://conductscience.org/library/papers/42213292PubMed
42129311
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging.
Bone Marrow Transplant2026https://conductscience.org/library/papers/42129311PubMed
42101313Neurolymphomatosis: A Comprehensive Review of Clinical and Imaging Features.Radiol Imaging Cancer2026https://conductscience.org/library/papers/42101313PubMed
42056569CXCR4-targeted PET/CT with [¹⁸F]AlF-NOTA-QHY-04 in primary central nervous system lymphoma: a prospective comparison with MRI and [¹⁸F]FDG PET/CT.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/42056569PubMed
41999193Efficacy and Safety Profile of a Rituximab, Methotrexate, and Thiotepa-Based Regimen in Newly Diagnosed Primary CNS Lymphoma.Int J Cancer2026https://conductscience.org/library/papers/41999193PubMed
41843467Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.Blood2026https://conductscience.org/library/papers/41843467PubMed
41785308Glofitamab crosses the blood-brain barrier and exhibits activity against primary and secondary CNS lymphoma.Blood Adv2026https://conductscience.org/library/papers/41785308PubMed
41696494Time matters: The prognostic impact of diagnostic delay on survival in primary central nervous system lymphoma-a single-center, retrospective real-world study.Neurooncol Adv2026https://conductscience.org/library/papers/41696494PubMed
41681925The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous System.Cancers (Basel)2026https://conductscience.org/library/papers/41681925PubMed

See all 105 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CXCL1310563PubTator's text mininghttps://conductscience.org/library/genes/10563NCBI Gene
FLT12321PubTator's text mininghttps://conductscience.org/library/genes/2321NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IRF43662PubTator's text mininghttps://conductscience.org/library/genes/3662NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33560416

GET https://conductscience.org/api/papers/v1/33560416/authors?page=2